PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-178

  1. 35,788 Posts.
    lightbulb Created with Sketch. 555
    to be fair, that’s 1 lady having a hissy fit..

    it’s every parents option they either use the drug(s) & take their perceived benefits or they don’t …

    and $3m is actually not some mindblowing price given it’s a 1 time therapy ….

    Sarepta internal data priced it at something like $15m ? given after ~5 years it becomes cheaper (free) vs Exondy’s … that’s where you get insurers starting to favour it….
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.